NCT05560321 is a NA clinical trial of Sani24 in Disinfection, sponsored by Duke University.

Who is sponsoring NCT05560321?

NCT05560321 is sponsored by Duke University.

What drugs are being tested in NCT05560321?

Interventions in NCT05560321: Sani24, Routine Disinfection.

What condition does NCT05560321 study?

NCT05560321 studies Disinfection.

Is NCT05560321 still recruiting?

NCT05560321 is currently completed. Last updated 29 September 2022.

Last reviewed 2022-09-29 · How we verify

NCT05560321

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Measuring the Impact of an Enhanced Strategy for Daily Disinfection in Acute Care Hospital Rooms

Completed NA Last updated 29 September 2022

What this trial tests

NA trial testing Sani24 in Disinfection in 50 participants. Completed in 17 March 2022.

Timeline

22 August 2019

Primary endpoint
17 March 2022

17 March 2022

Quick facts

Lead sponsor	Duke University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	basic science
Enrollment	50
Start date	22 August 2019
Primary completion	17 March 2022
Estimated completion	17 March 2022
Sites	1 location across United States

Drugs / interventions tested

Sani24
Routine Disinfection

Conditions studied

Disinfection — all drugs for Disinfection →

Sponsor

Duke University

Who can join

18 and older, any sex, with Disinfection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the effectiveness of an enhanced strategy for daily disinfection in acute care hospital rooms comparing the addition of sani24 to routine daily cleaning versus the control of routine daily cleaning.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

An Enhanced Strategy for Daily Disinfection in Acute Care Hospital Rooms: A Randomized Clinical Trial.
Warren BG, Barrett A, Graves A, King C, et al · · 2022 · cited 12× · PMID 36378308 · DOI 10.1001/jamanetworkopen.2022.42131

Verify or expand the search:

Other trials of Sani24

Trials testing the same drug.

NCT05739955 — Impact of Enhanced Daily Disinfection on Environmental Contamination in Hospital Rooms · NA · completed

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05560321 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 29 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05560321.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing